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Solid triglyceride nanoparticles are under intensive investigation as drug delivery systems. In the solid state, triglycerides 
exist in three polymorphic modifications which differ from each other in their physicochemical properties. Thus, it is 
particularly important to know the influence of parameters affecting the polymorphic behavior of the solid triglyceride 
nanoparticles to get a stable product with defined physicochemical properties over an appropriate storage time. This study 
investigated the effect of subsequent addition of SDS to tripalmitin nanoparticles, which had been stabilized with partially 
hydrolyzed poly(vinyl alcohol) (PVA). The polymorphic behavior was characterized with DSC and X-ray diffraction 
over a storage time of 28 d at 20 °C. A faster transition into more stable polymorphic modifications was observed after 
the addition of SDS to the nanoparticles.  
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INTRODUCTION 
Nanoparticles of solid lipids were first investigated by 
Speiser et al. [1986] and further developed as potential 
drug delivery systems for poorly water-soluble drugs 
[Bunjes, 2010]. The physicochemical properties of the 
nanoparticles depend on, e.g., the used matrix lipid, the 
stabilizer as well as additional substances. As matrix 
lipid e.g., triglycerides can be used. Triglycerides are 
polymorphic substances and mainly occur in three 
different polymorphic modifications. These 
modifications differ from each other in their 
physicochemical properties due to a different 
arrangement of the triglyceride molecules [Chapman, 
1962]. According to Ostwald’s step rule, triglycerides 
crystallize in the metastable α-modification and undergo 
time- and temperature dependent monotropic transitions 
into the stable β-modification, sometimes via the β’-
modification. The different physicochemical properties 
of the solid triglyceride particles when present in 
different crystal modifications might influence the drug 
loading capacity as well as the physical stability of the 
dispersion. Therefore, it is essential to understand the 
effect of additives to obtain a stable product over the 
necessary shelf life. In this study, tripalmitin was used 
as matrix lipid and the nanoparticles were stabilized 
with partially hydrolyzed poly(vinyl alcohol). SDS was 
added to the dispersions to investigate the effect on the 
physicochemical behavior of the PVA-stabilized 
nanoparticles and to get further information about how 
PVA interacts with the matrix lipid. 
 
RESEARCH CONCEPT 
For this study, dispersions consisting of 5 % tripalmitin 
(Dynasan® 116, Condea), 5, 7.5, 10 or 15 % Kuraray 
Poval 3-83 (Kuraray Europe GmbH) and bidestilled 
water, in which the PVA was dissolved, were prepared 
by high pressure melt homogenization (all 
concentrations w/w). To each dispersion 0.1 or 0.3 % 
SDS (Carl Roth GmbH) was added after the 
homogenization procedure as described in this section. 
A dispersion without SDS was used as reference.  
First, the lipid and the aqueous phase were heated at 
approx. 80 °C separately. Afterwards, both phases were 
combined and pre-homogenized with an ultra-turrax 
(IKA T25 digital Ultra-Turrax; SN25-10G, IKA-Werke) 
at 13.000 rpm for 4 min. The premix was homogenized 
in a preheated Microfluidizer M110-P instrument 
(Microfluidics) for 10 cycles at 800 bar. The hot 
dispersion was divided into three parts. To two parts 
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SDS in the respective concentration was added as a 
powder in the heat and dissolved under gentle shaking. 
In a following cooling step, the matrix lipid was allowed 
to crystallize in an ice-water bath.  
The particle size was measured with a Zetasizer Nano 
ZSP instrument (Malvern) at 25 °C and an angle of 
173 °. The dispersions were diluted with purified and 
particle free water. The z-average diameter and PDI 
were given as mean of three measurements of 5 min 
each after 5 min of equilibration. 
Differential scanning calorimetry (DSC) measurements 
were performed in a DSC 3 Stare System with a full 
range sensor (FRS 6+) and a sample robot (Mettler 
Toledo GmbH). 15 µl of the dispersions were accurately 
weighed into aluminum crucibles that were cold sealed. 
The samples were heated from 0 to 85 °C with a heating 
rate of 10 K/min, held at that temperature for 10 min and 
cooled to -5 °C with a cooling rate of 10 K/min. As a 
reference, an empty aluminum pan was used, and all 
measurements were performed under nitrogen purge. 
The enthalpies obtained as areas under the curve upon 
evaluation were normalized for the weight of the 
samples. 
The melting enthalpies were used to approximate the 
formation of particles in the stable β-modification. 
X-ray measurements were performed with a small- and 
wide-angle X-ray diffraction setup (SAXSess mc², 
Anton Paar) equipped with a copper radiation source 
(λ = 0.154 nm) and a CCD detector as well as a Mythen 
detector. The sample was measured in a quartz capillary 
sample holder in 20 runs of 60 s each at 20 °C. 
Background subtraction and desmearing was performed 
for all diffractograms. 
 
RESULTS 
All dispersions had a milky white appearance. However, 
the more PVA was used as emulsifier, the more 
transparent was the dispersion. After the addition of 
SDS, the appearance did not change. The z-average and 
PDI values were 75 - 100 nm or 0.10 - 0.20, 
respectively, and depended on two parameters. First, the 
more PVA was used, the smaller were the particles. 
Second, with addition of SDS the z-average and PDI 
values increased. This effect on the particle size was less 
pronounced when more PVA was used in the original 
dispersion. 
During cooling the sample in the DSC, the 
crystallization temperature increased with the addition 
of SDS from approx. 25 to 28 °C for tripalmitin 


















Figure 1: Wide angle X-ray diffractograms of 
tripalmitin nanoparticles. The composition of the 
dispersions was 5 % tripalmitin, 5 % Kuraray Poval 3-
83 and 0, 0.1 or 0.3 % SDS, respectively. The 
diffractograms were recorded after 0, 1, 4, 7, 14, 21 and 
28 d of storage at 20 °C. 
 
nanoparticles, which were stabilized with 5 % PVA. 
Comparable to the effect on the particle size, the 
influence on the crystallization temperature also 
decreased with increasing total PVA concentration in 
the sample. In this case, the crystallization temperature 
was nearly constant at 22 °C for dispersions, which were 
stabilized with a total PVA-concentration of 15 %. 
After crystallization, all particles were present in the 
metastable α-modification, which was confirmed with 
DSC and X-ray measurements. According to the SAXS 
patterns, the triglyceride in the lipid particles was 
arranged with a reduced lamellarity. The SAXS signals 
increased over the storage time for all samples. The 
0.3 % SDS-containing sample displayed additional 
signals in the wide-angle scattering pattern at approx. 
14.2 and 16.8 nm-1 (fig. 1). During the observed period 
of storage, the matrix lipid underwent time-dependent 
polymorphic transitions into more stable modifications. 
This could be confirmed with DSC measurements, 
which showed an increased size of the melting event at 
higher temperatures after 28 d of storage. 
In contrast, there were no indications for the presence of 
particles in the β’-modification in the wide-angle range 
of the sample without SDS (fig. 1). These effects were 
also observed for the dispersions stabilized with higher 
concentrations of PVA or only 0.1 % additional SDS. 
 
DISCUSSION 
The addition of SDS to tripalmitin nanodispersions 
stabilized with partially hydrolyzed PVA had an 
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influence on their physicochemical behavior. It is 
known that PVA has a strong stabilizing effect on 
metastable polymorphic modifications in triglyceride 
nanoparticles [Rosenblatt et al., 2008]. The assumption 
in the present study was that the stronger the interaction 
between PVA and the matrix lipid, the lower is the 
crystallization temperature and the higher the stability of 
the metastable α-modification. The increase of the 
crystallization temperature with increasing SDS 
concentration might be an indication that the interaction 
between the matrix lipid and PVA is weakened in 
comparison to the reference dispersion without SDS.  
Another indication for the reduction of the interaction 
between the matrix lipid and the main emulsifier, PVA, 
is the more pronounced polymorphic transition into 
more stable modifications. The particles with SDS 
addition transformed more rapidly into the β’-
modification, which could be detected in the WAXS-
pattern in fig. 1 [Chapman, 1962].  
A possible cause of the observed phenomena might be 
an interaction between PVA and the additional SDS, 
which might influence the stabilization properties of 
PVA. It is supposed that SDS associates with PVA thus 
leading to a stretching of the polymer [Ramirez, 2020]. 
This could cause a more hydrophilic character of PVA. 
Consequently, the interaction between PVA and the 
matrix lipid would be reduced, which is reflected in the 
increasing crystallization temperature of the triglyceride 
nanoparticles. 
The higher the PVA concentration, the lower is the 
effect of SDS addition on the observed effects on the 
crystallization temperature as well as on the particle 
sizes and the polymorphic behavior of the solid 
triglyceride nanoparticles. 
This concentration dependent effect could be due to the 
relatively low SDS concentration in comparison to the 
high PVA concentration. Possibly, the SDS 
concentration is not high enough to exhibit a major 
effect on the high number of PVA molecules, which are 
located at the particle surface, or is preferably associated 
with free PVA molecules, which are assumed to be 
present in the aqueous phase. 
There were no clear indications that SDS acts as main 
stabilizer by adding it after homogenization. A 
particularly prominent indication that PVA was still the 
main stabilizer is the less ordered structure of the 
particles after crystallization, which was not observed 




This study indicated that PVA-stabilized solid 
tripalmitin nanoparticles can undergo polymorphic 
transitions into more stable modifications more easily 
after the addition of SDS. This knowledge is important 
for the estimation of the stability of the product as 
potential drug delivery system. Furthermore, the 
addition of SDS might contribute to a better 
understanding of how PVA physically stabilizes the 
triglyceride nanoparticles and induces such a high 
stability of the metastable α-polymorph.    
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